Logo image of EAD.DE

ERLEBNIS AKADEMIE AG (EAD.DE) Stock Fundamental Analysis

FRA:EAD - Deutsche Boerse Ag - DE0001644565 - Common Stock - Currency: EUR

4.18  +0.1 (+2.45%)

Fundamental Rating

4

Taking everything into account, EAD scores 4 out of 10 in our fundamental rating. EAD was compared to 55 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of EAD is average, but there are quite some concerns on its profitability. EAD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year EAD has reported negative net income.
In the past year EAD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: EAD reported negative net income in multiple years.
In the past 5 years EAD always reported a positive cash flow from operatings.
EAD.DE Yearly Net Income VS EBIT VS OCF VS FCFEAD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.81%, EAD is doing worse than 69.09% of the companies in the same industry.
The Return On Equity of EAD (-12.54%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.81%
ROE -12.54%
ROIC N/A
ROA(3y)-0.88%
ROA(5y)0.18%
ROE(3y)-2.48%
ROE(5y)0.35%
ROIC(3y)N/A
ROIC(5y)N/A
EAD.DE Yearly ROA, ROE, ROICEAD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

EAD's Gross Margin of 89.29% is amongst the best of the industry. EAD outperforms 89.09% of its industry peers.
In the last couple of years the Gross Margin of EAD has remained more or less at the same level.
EAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.87%
GM growth 5Y-0.58%
EAD.DE Yearly Profit, Operating, Gross MarginsEAD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

5

2. Health

2.1 Basic Checks

EAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
EAD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EAD has more shares outstanding
EAD has a better debt/assets ratio than last year.
EAD.DE Yearly Shares OutstandingEAD.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
EAD.DE Yearly Total Debt VS Total AssetsEAD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

EAD has an Altman-Z score of 1.43. This is a bad value and indicates that EAD is not financially healthy and even has some risk of bankruptcy.
EAD has a Altman-Z score (1.43) which is comparable to the rest of the industry.
EAD has a debt to FCF ratio of 6.51. This is a slightly negative value and a sign of low solvency as EAD would need 6.51 years to pay back of all of its debts.
EAD has a Debt to FCF ratio of 6.51. This is comparable to the rest of the industry: EAD outperforms 58.18% of its industry peers.
A Debt/Equity ratio of 1.18 is on the high side and indicates that EAD has dependencies on debt financing.
EAD has a Debt to Equity ratio (1.18) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 6.51
Altman-Z 1.43
ROIC/WACCN/A
WACC5.26%
EAD.DE Yearly LT Debt VS Equity VS FCFEAD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 4.52 indicates that EAD has no problem at all paying its short term obligations.
EAD has a better Current ratio (4.52) than 100.00% of its industry peers.
EAD has a Quick Ratio of 3.19. This indicates that EAD is financially healthy and has no problem in meeting its short term obligations.
EAD's Quick ratio of 3.19 is amongst the best of the industry. EAD outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.52
Quick Ratio 3.19
EAD.DE Yearly Current Assets VS Current LiabilitesEAD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

4

3. Growth

3.1 Past

The earnings per share for EAD have decreased strongly by -81.58% in the last year.
The Revenue has been growing slightly by 1.16% in the past year.
The Revenue has been growing by 21.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-81.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.57%
Revenue 1Y (TTM)1.16%
Revenue growth 3Y16.89%
Revenue growth 5Y21.51%
Sales Q2Q%0.11%

3.2 Future

The Earnings Per Share is expected to grow by 37.80% on average over the next years. This is a very strong growth
EAD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.04% yearly.
EPS Next Y51.67%
EPS Next 2Y55.46%
EPS Next 3Y37.8%
EPS Next 5YN/A
Revenue Next Year5.51%
Revenue Next 2Y2.72%
Revenue Next 3Y1.67%
Revenue Next 5Y1.04%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EAD.DE Yearly Revenue VS EstimatesEAD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5M 10M 15M 20M 25M
EAD.DE Yearly EPS VS EstimatesEAD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EAD. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 16.55, the valuation of EAD can be described as correct.
70.91% of the companies in the same industry are more expensive than EAD, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, EAD is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 16.55
EAD.DE Price Earnings VS Forward Price EarningsEAD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

76.36% of the companies in the same industry are more expensive than EAD, based on the Enterprise Value to EBITDA ratio.
EAD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EAD is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.78
EV/EBITDA 6.33
EAD.DE Per share dataEAD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EAD's earnings are expected to grow with 37.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.46%
EPS Next 3Y37.8%

0

5. Dividend

5.1 Amount

No dividends for EAD!.
Industry RankSector Rank
Dividend Yield N/A

ERLEBNIS AKADEMIE AG

FRA:EAD (3/7/2025, 7:00:00 PM)

4.18

+0.1 (+2.45%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-25 2024-11-25
Earnings (Next)04-06 2025-04-06/amc
Inst Owners5.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.53M
Analysts80
Price Target12.85 (207.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-32.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-156.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.55
P/S 0.28
P/FCF 2.78
P/OCF 2.27
P/B 0.5
P/tB 0.51
EV/EBITDA 6.33
EPS(TTM)-1.03
EYN/A
EPS(NY)0.25
Fwd EY6.04%
FCF(TTM)1.5
FCFY35.93%
OCF(TTM)1.84
OCFY43.98%
SpS14.93
BVpS8.31
TBVpS8.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.81%
ROE -12.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.29%
FCFM 10.06%
ROA(3y)-0.88%
ROA(5y)0.18%
ROE(3y)-2.48%
ROE(5y)0.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.87%
GM growth 5Y-0.58%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 6.51
Debt/EBITDA 4.8
Cap/Depr 14.34%
Cap/Sales 2.25%
Interest Coverage N/A
Cash Conversion 90.18%
Profit Quality N/A
Current Ratio 4.52
Quick Ratio 3.19
Altman-Z 1.43
F-Score5
WACC5.26%
ROIC/WACCN/A
Cap/Depr(3y)226.34%
Cap/Depr(5y)241.2%
Cap/Sales(3y)62.98%
Cap/Sales(5y)63.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.57%
EPS Next Y51.67%
EPS Next 2Y55.46%
EPS Next 3Y37.8%
EPS Next 5YN/A
Revenue 1Y (TTM)1.16%
Revenue growth 3Y16.89%
Revenue growth 5Y21.51%
Sales Q2Q%0.11%
Revenue Next Year5.51%
Revenue Next 2Y2.72%
Revenue Next 3Y1.67%
Revenue Next 5Y1.04%
EBIT growth 1Y-589.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2100%
EBIT Next 3Y180.2%
EBIT Next 5YN/A
FCF growth 1Y122.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.27%
OCF growth 3Y-7.04%
OCF growth 5Y-0.39%